Roche Diagnostics

/Roche Diagnostics
­
2 05, 2016

Siemens Healthcare and Roche Diagnostics Lead the US Immunochemistry Market – Reports iData

By |May 2nd, 2016|Roche Diagnostics, Siemens Healthcare|Comments Off on Siemens Healthcare and Roche Diagnostics Lead the US Immunochemistry Market – Reports iData

As per the latest report on the in-vitro diagnostics device market from iData Research, increasing immunoassay test volumes is the major factor that drives growth in the immunochemistry market. The growth may be the result of high incidence of cardiovascular disorders and cancers among aging baby boomers coupled with unhealthy lifestyle choices. The report that [...]

1 06, 2015

Roche Cobas Liat PCR System and Strep A Assay Get FDA CLIA Waiver

By |June 1st, 2015|Roche Diagnostics|Comments Off on Roche Cobas Liat PCR System and Strep A Assay Get FDA CLIA Waiver

Roche Diagnostics is a pioneer in creating innovative medicines and diagnostic tests that help millions of patients globally. The U.S. Food and Drug Administration (FDA) recently granted CLIA (Clinical Laboratory Improvement Amendments) waiver for Roche’s cobas® Strep A test for use on the cobas® Liat System. CLIA (Clinical Laboratory Improvement Amendments) is a lab testing [...]

4 02, 2015

World Cancer Day 2015 – Focus on Prevention, Early Detection, Treatment and Care

By |February 4th, 2015|Roche Diagnostics|Comments Off on World Cancer Day 2015 – Focus on Prevention, Early Detection, Treatment and Care

Cancer is a major challenge for healthcare. According to the Cancer Facts & Figures 2015 released by the American Cancer Society, there will be an estimated 1,658,370 new cancer cases diagnosed and 589,430 cancer deaths in the US this year. The report also finds that the most common causes of cancer death are lung, prostate, [...]

15 01, 2015

Roche Launches New Viral Load Testing Assays for its Automated Molecular Diagnostic Systems

By |January 15th, 2015|Roche Diagnostics|Comments Off on Roche Launches New Viral Load Testing Assays for its Automated Molecular Diagnostic Systems

Roche has introduced new viral load monitoring assays, cobas HIV-1 and cobas HCV assays, for use on its fully automated molecular diagnostic systems, cobas 6800/8800. With these next generation viral load monitoring assays, clinicians can manage the treatment of patients infected with human immunodeficiency virus (HIV-1) or hepatitis C (HCV). The viral load portfolio on [...]

6 01, 2015

January is Cervical Health Awareness Month

By |January 6th, 2015|Cervical Cancer, Roche Diagnostics|Comments Off on January is Cervical Health Awareness Month

Cervical cancer is the second leading cancer affecting women worldwide. The U.S. congress has named January as the month for cervical cancer awareness. The NCCC (National Cervical Cancer Coalition) and its local chapters spread awareness about the disease and the importance of early detection. HPV or the Human Papillomavirus is the most common cause of [...]

27 11, 2014

Roche Cobas HPV Test – An Efficient Option for Primary Cervical Cancer Screening

By |November 27th, 2014|Cervical Cancer, Roche Diagnostics|Comments Off on Roche Cobas HPV Test – An Efficient Option for Primary Cervical Cancer Screening

According to the American Cancer Society, cervical cancer is one of the most successfully treatable cancers if detected early. Cervical cancer can sometimes be found early and even prevented entirely by having regular Pap tests, which examine cervical cells for changes indicative of cervical cancer. However, studies show that Pap cytology can have high false-negative [...]

9 10, 2014

Rapid Tests Leading to More Improved Use of Antibiotics

By |October 9th, 2014|Molecular Diagnostics, Roche Diagnostics|Comments Off on Rapid Tests Leading to More Improved Use of Antibiotics

Antimicrobial resistance is an increasingly serious threat to global public health. World Health Organization's (WHO) report published in April 2014 states that "Antibiotic resistance - when bacteria change so antibiotics no longer work in people who need them to treat infections - is now a major threat to public health". The results of a recent [...]

11 09, 2014

Researchers Develop Universal Blood Test for Cancer Diagnosis

By |September 11th, 2014|Blood Testing, Roche Diagnostics|Comments Off on Researchers Develop Universal Blood Test for Cancer Diagnosis

According to the reports from the American Cancer Society, cancer remains the second most common cause of death in the US, accounting for nearly 1 of every 4 deaths. Diagnosing cancer involves the use of a variety of tests that provide details about abnormal cells. When making a diagnosis, the initial signs and symptoms are [...]

20 05, 2014

Roche Wins FDA Approval for Alternative to Pap Smear

By |May 20th, 2014|Roche Diagnostics|Comments Off on Roche Wins FDA Approval for Alternative to Pap Smear

According to the National Institutes of Health, about 12,360 women will be diagnosed with cervical cancer in 2014 and 4,020 will die from the disease. Early detection can possibly help the disease from developing. Women now have hope with a new genetic test from Roche Holding AG (ROG). The Food and Drug Administration (FDA) has [...]